Welcome to our dedicated page for Danaher Corporation news (Ticker: $DHR), a resource for investors and traders seeking the latest updates and insights on Danaher Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Danaher Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Danaher Corporation's position in the market.
Danaher will have its President and CEO present at the Bank of America Securities Healthcare Conference in Las Vegas on May 14, 2024. The event will be webcasted on the company's website.
Danaher (NYSE: DHR) declared a regular quarterly cash dividend of $0.27 per share for its common stock. The dividend will be paid on July 26, 2024, to shareholders of record on June 28, 2024.
Curiox Biosystems and Beckman Coulter Life Sciences have announced a partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry, combining C-FREE™ technology with DURA Innovations. The collaboration aims to address challenges in standardization, automation, and reproducibility, paving the way for advancements in research and healthcare.